Coyoacan, Mexico Clinical Trials

A listing of Coyoacan, Mexico clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
measurable disease
stage iv non-small cell lung cancer
non-squamous non-small cell lung cancer
docetaxel
Investigational Site Number 4840002
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +168 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
migraine
preventive medication
lasmiditan
Hospital Infantil de Mexico Federico G mez
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
Carfilzomib Daratumumab Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Carfilzomib in combination with lenalidomide, daratumumab and dexamethasone (KRDd) can induce profound clinical responses. The investigators want to observe the effectiveness of the quadruple therapy of carfilzomib, lenalidomide, daratumumab and dexamethasone on patients receiving 8 cycles of KRDd with autologous stem cell transplantation versus patients with 8 cycles of KRDd …

lenalidomide
autologous hematopoietic stem cell transplant
renal failure
bone marrow procedure
anemia
Grupo Cooperativo de Hemopat as Malignas
 (9.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD

Cardiovascular diseases (CVD) are the leading cause of death in the world and our country. The prevalence of Heart Failure (HF) is 1-2% in the adult population in developed countries, up to 10% among people 70 years of age. Concerning COPD, it is estimated that by 2030 will be the …

pulmonary function tests
lung disorder
pulmonary disease
bronchodilator
pulmonary function test
Dulce Gonz lez-Islas
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19

The SARS-CoV-2 infection in the airway epithelium induces cytopathic effects and the cessation of ciliary movement. Increased cytokines and chemokines have been reported to be associated with the severity of the disease. However, most of the molecular and cellular aspects of the inflammatory response and the processes of development of …

inflammatory response
cytokines
SARS
covid-19
acute respiratory syndrome (sars)
UMAE Hospital de Especialidades del Centro M dico Nacional Siglo XXI, IMSS.
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia

Background: Mexico City has one of the highest incidences and mortality rates of acute lymphoblastic leukemia (ALL) in the world and a high frequency of early relapses (17%) and early mortality (15%). Otherwise, childhood overweight and obesity are reaching epidemic proportions. They have been associated with poor outcomes in children …

leukemia
lymphoblastic leukemia
overweight and obesity
acute lymphoblastic leukemia
aspiration
Hospital General Regional Num 1 Carlos McGregor S nchez Navarro, IMSS
 (3.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations